Detalhe da pesquisa
1.
Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients.
Anticancer Drugs
; 33(1): e541-e547, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34387597
2.
Predictive factors of survival outcomes in first-line therapy for metastatic castration-resistant prostate cancer.
Int J Urol
; 29(1): 26-32, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34549837
3.
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.
Cancer Invest
; 39(3): 251-256, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33393849
4.
Prognostic impact of prior local therapy in castration-resistant prostate cancer.
Jpn J Clin Oncol
; 51(7): 1142-1148, 2021 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33621330
5.
Effect of Smoking on Oncological Outcome among Prostate Cancer Patients after Radical Prostatectomy with Neoadjuvant Hormonal Therapy.
Cancer Invest
; 38(10): 559-564, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33016145
6.
Smoking effect on oncological outcome among men with prostate cancer after radical prostatectomy.
Jpn J Clin Oncol
; 47(5): 453-457, 2017 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28184442
7.
Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare.
BJU Int
; 118(6): 880-884, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26991851
8.
Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer.
Prostate Int
; 10(1): 50-55, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35510101
9.
Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer.
Prostate Int
; 10(1): 7-13, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35229000
10.
Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors.
JMA J
; 5(1): 83-90, 2022 Jan 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35224264
11.
Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer.
Anticancer Res
; 41(11): 5593-5598, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34732430
12.
Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer.
Anticancer Res
; 41(8): 3885-3889, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34281850
13.
The prognosis and the impact of radiotherapy in clinically regional lymph node-positive prostate cancer: Which patients are candidates for local therapy with radiation?
Urol Oncol
; 38(12): 931.e1-931.e7, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32900626